Natriuretic Peptides - Predictors of In-hospital and Long-term Major Adverse Cardiac Events After Emergency Surgery?
This trial is active, not recruiting.
|Condition||3 years cardiac morbidity and mortality|
|Sponsor||Medical University of Graz|
|Start date||February 2008|
|End date||December 2013|
|Trial size||302 participants|
|Trial identifier||NCT00942786, 19-077 ex 07/08|
The investigators hypothesize that the level of perioperative natriuretic peptides is associated with in-hospital and long term major adverse cardiac events.
Consecutive patients undergoing emergency surgery
Major adverse cardiac event
time frame: in-hospital and during 3 years follow-up
Male or female participants at least 50 years old.
Inclusion criteria: - Emergency surgery: 1. Vascular 2. Intra-abdominal 3. Orthopedic Exclusion Criteria: - Patients unable to provide informed consent - Thoracic surgery - Trauma surgery
|Official title||Prospective Study to Evaluate the Predictive Value of Brain Natriuretic Peptides for Adverse Long-term Cardiac Outcome|
|Principal investigator||Elisabeth Mahla, M.D.|
|Description||The purpose of the study is to measure levels of brain natriuretic peptides before and after urgent non-cardiac surgery and to evaluate their predictive value for adverse long-term outcome.|
Call for more information